Sancilio & Company, Inc. (SCI) is an integrated pharmaceutical company that focuses on developing and marketing a variety of products, including those based on the proprietary Advanced Lipid Technologies® (ALT®) platform.  We can help with your product development needs!

WELCOME TO SANCILIO & COMPANY, INC.

Our Mission Is To Save One Million Lives

Sancilio & Company, Inc. is a wholly-owned subsidiary of Sancilio Pharmaceuticals Company, Inc. based in Riviera Beach, FL.

As an integrated pharmaceutical company, SCI is focused on developing and marketing a variety of drug and nutraceutical products, including those based on the proprietary Advanced Lipid Technologies® (ALT®) platform.

In addition to our primary goal of developing proprietary pharmaceutical products through the use of ALT® technology, we also offer services to third parties. SCI offers product development, manufacturing of soft gel capsules, and contract product sales. For certain development projects, SCI may partner with a third party to leverage the ALT® platform for delivery of a third party’s lipophilic compound.

We manufacture our products in state-of-the-art FDA inspected cGMP facilities, and offer our manufacturing suites for the production of a variety of drug products, including potent compounds requiring containment, such as hormone drugs.

SCI was awarded “Manufacturer of the Year” Award in 2015 by the South Florida Manufacturing Association.

MORE ABOUT US

PRODUCT DEVELOPMENT SERVICES

COLLABORATION

SCI is continuously expanding our US and global strategic partnerships. As a US based, fully integrated specialty pharmaceutical company SCI can provide assistance to your project whether you are looking for Soft Gel Hormone Manufacturing, contract Soft Gel Manufacturing, leveraging SCI’s platform Advanced Lipid Technologies® to clinically improve your lipophilic drug candidate, expanding your current drug portfolio through In-Licensing agreements or seeking to establish or expand the US marketing and distribution of your approved drugs.  To learn more about how we can partner with you, contact us to learn more about the various ways SCI can provide value to your organization.

WHAT IS ALT®

Advanced Lipid Technologies® (ALT®) is Sancilio & Company’s (SCI) proprietary drug delivery platform, which leverages SCI’s patented and trade secreted formulation and manufacturing techniques to create lipophilic drug products capable of increased bioavailability, avoidance of the first pass effect, and elimination of the food effects commonly associated with oral administration.

“Manufacturer of the Year” Award Winner
Year 2015

SCI was awarded “Manufacturer of the Year” Award in 2015 by the South Florida Manufacturing Association.